Brief: Windtree Therapeutics Got Letter From Nasdaq Notifying Closing Bid Price For Co's Common Stock Has Been Below Minimum Required For Continued Listing
22/01/2024 21:56
Windtree Therapeutics Inc WINT.O :
* WINDTREE THERAPEUTICS: GOT LETTER FROM NASDAQ NOTIFYING
CLOSING
BID PRICE FOR CO'S COMMON STOCK HAS BEEN BELOW MINIMUM REQUIRED
FOR CONTINUED LISTING
Source text for Eikon: ID:
Further company coverage: WINT.O
Recent news on Windtree Therapeutics
See all newsBrief: Windtree Therapeutics Announces It Has Signed A Letter Of Intent To Acquire Commloan
Brief: Windtree Therapeutics Announces It May Receive License Agreement Payments From Its Licensee For Renewed Acute Pulmonary Development By The Licensee
Brief: Windtree Therapeutics Stockholders Approve Key Proposals For Revenue And Profit Generation At The Special Stockholder Meeting
Brief: Windtree Therapeutics Terminates Seismic-C Clinical Study At 20 Enrollments - SEC Filing
Brief: Windtree Therapeutics Inc - Announces Interim Analysis Of Istaroxime Phase 2 Study